Search Within

William D Travis

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (7)
  3. Book Whole (2)
Groups
  1. Department of Medicine (16)
  2. Department of Pathology and Laboratory Medicine (16)
  3. Molecular Pharmacology and Chemistry Program Faculty (16)
  4. Sloan Kettering Institute Faculty (16)
  5. GSK Faculty (14)
  6. Hematologic Malignancies, Division of (14)

More Groups

People
  1. Prasad Adusumilli (11)
  2. Valerie Rusch (11)
  3. Michel Sadelain (10)
  4. Kyuichi Kadota (7)
  5. Hideki Ujiie (4)
  6. Camelia Sima (3)

More People

Years
  1. 2021 (1)
  2. 2017 (1)
  3. 2015 (2)
  4. 2014 (1)
  5. 2013 (4)
  6. 2011 (2)

More Years

Publications
  1. Journal of Thoracic Oncology (5)
  2. Cancer Immunology, Immunotherapy (2)
  3. Journal of Clinical Oncology (2)
  4. AJCC Cancer Staging Manual. 7th ed (1)
  5. AJCC cancer staging handbook: From the AJCC cancer staging manual. 7th ed (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. Elsevier Inc. (5)
  2. Springer (4)
  3. American Association for Cancer Research (3)
  4. American Society of Clinical Oncology (2)
  5. American Society for Clinical Investigation (1)
  6. Impact Journals (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: Expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
    Journal Article

    Eguchi, T.; Kadota, K.; Mayor, M.; Zauderer, M. G.; Rimner, A.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Targetable cancer-associated antigens for immunotherapy in malignant pleural mesothelioma (MPM) — Mesothelin, CA125 and WT-1
    Meeting Abstract

    Ujiie, H.; Eguchi, T.; Mayor, M.; Kadota, K.; Travis, W. D.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma
    Meeting Abstract

    Eguchi, T.; Ujiie, H.; Morello, A.; Kadota, K.; Buitrago, D. H.; Woo, K.; Jones, D. R.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma
    Journal Article

    Kachala, S. S.; Bograd, A. J.; Villena-Vargas, J.; Suzuki, K.; Servais, E. L.; Kadota, K.; Chou, J.; Sima, C. S.; Vertes, E.; Rusch, V. W.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • CD8 T-cell infiltration and tumor IL-7R expression are independent prognostic factors in epithelioid malignant pleural mesothelioma
    Meeting Abstract

    Ujiie, H.; Buitrago, D.; Nitadori, J.; Kadota, K.; Krug, L. M.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer: Implications for immunotherapy
    Meeting Abstract

    Lee, M. C.; Kadota, K.; Ujiie, H.; Rizk, N. P.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic impact of tumor-infiltrating immune cells in lung squamous cell carcinoma
    Meeting Abstract

    Bograd, A.; Kadota, K.; Nitadori, J.; Cherkassky, L.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence
    Journal Article

    Suzuki, K.; Kadota, K.; Sima, C. S.; Nitadori, J.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save